SCHEMBL6142182

SCHEMBL6142182

Cc1cccc(Cl)c1C(=O)[AsH]C(Cc1ccc2nc(-c3c(C(F)(F)F)nn(C)c3Cl)ccc2c1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 17/20 0.47
ITGAV P06756 1/20 0.47
ITGA4 P13612 16/20 0.37
ITGB7 P26010 13/20 0.37
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3314948 0.85 ITGB1 (0.67) ITGB1ITGAVITGA4ITGB7
SCHEMBL4625192 0.82 ITGB1 (0.73) ITGB1ITGAVITGA4ITGB7
SCHEMBL6142370 0.81 ITGB1 (0.66) ITGB1ITGAVITGA4ITGB7KCNH2
SCHEMBL6140590 0.77 ITGB1 (0.56) ITGB1ITGAVITGA4ITGB7
SCHEMBL4625313 0.77 ITGB1 (0.55) ITGB1ITGAVITGA4ITGB7
SCHEMBL6140931 0.76 ITGB1 (0.54) ITGB1ITGAVITGA4ITGB7
SCHEMBL6151313 0.73 ITGB1 (0.52) ITGB1ITGAVITGA4ITGB7KCNH2
SCHEMBL6141061 0.72 ITGB1 (0.55) ITGB1ITGAVITGA4ITGB7KCNH2
SCHEMBL3314968 0.70 ITGB1 (0.87) ITGB1ITGAVITGA4ITGB7
SCHEMBL6141570 0.70 ITGB1 (0.43) ITGB1ITGAVITGA4ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2005-02-02 EP claimed
WO-2003093237-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2003-11-13 WO claimed